Hollow Brook Wealth Management’s GSK GSK Stock Holding History

Hollow Brook Wealth Management’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-32,078	Closed	-$1.75M	–	78
2022 Q2	$1.75M	Sell	32,078 -603	-2%	-$33.3K	0.96%	27
2022 Q1	$1.78M	Sell	32,681 -204	-0.6%	-$11.1K	0.79%	31
2021 Q4	$1.81M	Buy	32,885 +2,610	+9%	+$136K	0.93%	28
2021 Q3	$1.45M	Sell	30,275 -255	-0.8%	-$12.8K	0.9%	30
2021 Q2	$1.52M	Buy	+30,530	New	+$1.47M	0.94%	27

Other funds holding GSK

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fidelity Investments

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Fisher Asset Management

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

T. Rowe Price Associates

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Capital International Investors

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Renaissance Technologies

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Arrowstreet Capital

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Two Sigma Investments

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return